Pharmafile Logo

Focus on Rare Diseases

As pharma becomes more focused on rare disease therapies, Lucid Group recognises that medical education agencies need to respond.

- PMLiVE
The US government passed the Orphan Drug Act in 1983, and it was subsequently adopted in other key markets, most notably in Japan in 1993 and the European Union in 2000. Growth in this sector has remained around 12% annually, which is more than double that experienced in the general drug market. According to the 2015 Orphan Drug Report, worldwide orphan drug sales will reach $178 billion by 2020 and will account for 20% of all prescription drug sales by 2020*. 

The trend is clear: as science and technology advances, and the rise of the internet and social media enables patients and researchers to gather and share information more effectively, we are seeing treatments for rare diseases that only a few years ago would have led to an early death. 

Alison Cantle, Rare Disease Business Unit Director at Lucid Group, explains what this means for medical education agencies: “As pharmaceutical organisations focus on personalised medicine, the need for rare disease expertise in their medical education agencies is paramount. Lucid recognised this and structured its business last year to create a unit specialising in rare diseases.” 

Within this unit, Lucid Group had recruited a team of highly skilled medical writers who combine a deep and robust understanding of the science with experience of working with rare disease specialists across the globe.

“Our rare disease team understands the cornerstones of rare disease education and what makes it different from other therapy areas. It is essential to build networks and enable best practice sharing,” Alison explains. “And in rare disease, more so than in any other therapy area, the choice of agency is crucial, as often it is your agency who represents your organisation at the communication level – so its voice has to be your voice.” 

Patients who have a rare disease face difficulty in every step of medical care, including diagnosis, treatment and preserving quality of life. Sometimes, patients go years without receiving the correct diagnosis for their condition. So raising awareness, improving time to diagnosis, getting patients to the right care, and improving family and emotional support and reimbursement are just some of the areas where medical education agencies can support pharma clients. 

Lucid’s Rare Disease Business Unit currently works with clients in Fabry disease, Pompe disease, Gaucher disease, cystinosis and PKU.  For further information about working with Lucid’s Rare Disease Business Unit, please call Alison on 01494 552078 or email alison@lucid-uk.com. 

* EvaluatePharma Orphan Drug Report 2015

This content was provided by Lucid Group Communications Limited

Company Details

 Latest Content from  Lucid Group Communications Limited 

It’s been altogether more magic for Lucid Group in 2019

As Lucid closes its doors to 2019, there's a lot to be proud of.2019 has been a landmark year for the Group as they embarked on ambitious growth plans which...

Middlesex House hosts its first Lucid Spirit pub quiz

Dec 6, 2019Middlesex House hosted its first Lucid Spirit fundraising activity for its charity partner the Wycombe Homeless Connection. The turnout was excellent, and everyone’s synapses were on fire. However,...

Lucid Group announces the appointment of a new Legal and Compliance manager

Lucid Group demonstrates continual investment in its infrastructure by appointing Sebastian Goodwin as its new Legal and Compliance manager.Sebastian studied politics and trained to be a lawyer before moving into...

Lucid Group Experience the Magic of Mindfulness, Meditation and Massage

This time of year can be busier than normal. Lucid Group understand the importance of taking some time out to relax and unwind. That's why yesterday, relaxation, meditation and mindfulness...

The first of many celebrations for Lucid Group at Middlesex House

Lucid Group celebrated the opening of its new offices in Fitzrovia, London on Thursday evening. The workspace in Middlesex House is incredible, allowing employees to take advantage of well-designed creative,...

Lucid Group welcomes three new graduates ahead of the 2020 Futures Academy

Three new graduates have joined the Lucid Group family ahead of the launch of the 2020 Futures Academy in January.Having completed a Natural Sciences degree from Lancaster University, Tom Harrison...

Restoring Equilibrium at Lucid Group

It’s National Stress Awareness Day, which is a great opportunity to take a moment to think about our wellbeing. This time of year is often busier than normal. At Lucid,...

Lucid Group celebrates a fang-tastic Halloween

Last week the Lucid charity working group, Lucid SPIRIT, organised a fang-tastic Halloween Bingo evening to raise money for its charity partner, Wycombe Homeless Connection (WHC).Lucidians went to town with...

Lucid Group tough it out with a weekend full of charity challenges

This weekend the Lucid charity working group, Lucid SPIRIT, took on two separate challenges to help raise funds for the Wycombe Homeless Connection and Children in Need.On Saturday seventeen Lucidians...

#LucidLife is just about to get better with the move to Middlesex House

With only a few weeks to go Jan Steele, Lucid co-founder and COO discusses how the move to Middlesex House supports its commitment to making Lucid a great place to...